RAJIV ANAND, M.D.
Ophthalmology Physician · DALLAS, TX
Individual Active NPI 1508865254
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,154 | 20,033 | $4,815,719 | $1,745,203 | $1,356,470 |
| 2023 | 1,257 | 9,753 | $4,979,808 | $1,792,326 | $1,390,656 |
| 2022 | 1,286 | 7,477 | $4,300,697 | $1,591,517 | $1,225,057 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 13,020 | $35 | $27 |
| 92134 | Imaging of retina | 2,138 | $41 | $31 |
| 92014 | Established patient complete exam of visual system | 1,703 | $129 | $91 |
| J0178 | Injection, aflibercept, 1 mg | 742 | $829 | $660 |
| 67028 | Injection of drug into eye | 700 | $115 | $85 |
| 92004 | New patient complete exam of visual system | 257 | $153 | $111 |
| 92012 | Established patient problem focused exam of visual system | 201 | $91 | $61 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 189 | $175 | $141 |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 186 | $322 | $256 |
| J2778 | Injection, ranibizumab, 0.1 mg | 108 | $171 | $136 |
| 76512 | 2d ultrasound scan of eye tissue and structures | 62 | $48 | $39 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 58 | $168 | $130 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | H5505 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1083175558
- NPI 1386010122
- NPI 1679716948
- NPI 1538801063
- NPI 1114567476
- NPI 1275594376
- NPI 1124551163
- NPI 1093202004
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.